Analysts recommendations
Compugroup Medical: Warburg Research gives a Neutral rating. The target price is still set at EUR 87.
Glaxosmithkline: JP Morgan analyst James Gordon maintains his Neutral opinion on the stock. The target price is reduced from GBX 1650 to GBX 1500.
Qiagen: Jefferies confirms his opinion on the stock and remains Neutral. The target price is unchanged and still at EUR 46.
TUI: In his latest research note, analyst James Wheatcroft confirms his negative recommendation. The broker Jefferies is keeping its Sell rating. The target price has been revised downwards and is now set at EUR 1.00 as compared to EUR 2.80 previously.
Linde: In his latest research note, analyst Andrew Stott confirms his positive recommendation. The broker UBS is keeping its Buy rating. The target price is increased from EUR 235 to EUR 250.
Covestro: Andrew Stott from UBS retains his negative opinion on the stock with a Sell rating. Previously set at EUR 37, the target price has been raised to EUR 41.
Symrise: In a research note published by Andrew Stott, UBS advises its customers to buy the stock. The target price is still set at EUR 120.
Air Liquide: In a research note published by Andrew Stott, UBS advises its customers to buy the stock. The target price remains set at EUR 156.
WPP: In a research note published by Daniel Kerven, JP Morgan advises its customers to buy the stock. The target price is being increased from GBX 750 to GBX 960.
Akzo Nobel: UBS changes its rating and switches from Buy to Neutral. The target price is lowered from EUR 102 to EUR 95.
Basf: UBS’s analyst Andrew Stott has upgraded his rating from Neutral to Buy. The target price has been raised from EUR 56 to EUR 70.
Deutsche Telekom: In his latest research note, analyst Akhil Dattani confirms his positive recommendation. The broker JP Morgan is keeping its Buy rating. The target price is slightly modified from 23.60 to 23.50 EUR.
